|
BAZ2A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.79190004448537E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.14450029850855E-10 |
| Normal-vs-Stage2 |
8.540000E-03 |
| Normal-vs-Stage3 |
1.020810E-04 |
| Normal-vs-Stage4 |
4.823100E-03 |
| Stage1-vs-Stage2 |
2.685800E-01 |
| Stage1-vs-Stage3 |
2.195000E-01 |
| Stage1-vs-Stage4 |
5.191600E-02 |
| Stage2-vs-Stage3 |
8.646400E-01 |
| Stage2-vs-Stage4 |
6.579800E-01 |
| Stage3-vs-Stage4 |
4.574200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.39879999092341E-09 |
| Normal-vs-AfricanAmerican |
1.591860E-02 |
| Normal-vs-Asian |
1.153740E-02 |
| Caucasian-vs-AfricanAmerican |
3.900000E-01 |
| Caucasian-vs-Asian |
2.068500E-02 |
| AfricanAmerican-vs-Asian |
1.996130E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99420000002171E-06 |
| Normal-vs-Female |
8.59310400613822E-11 |
| Male-vs-Female |
4.442500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.623840E-01 |
| Normal-vs-Age(41-60Yrs) |
4.65089999845958E-09 |
| Normal-vs-Age(61-80Yrs) |
2.99350000010357E-07 |
| Normal-vs-Age(81-100Yrs) |
1.366560E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.038800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.791400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.455200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.445600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.866400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.208400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.79339884556862E-11 |
| Normal-vs-Grade 2 |
6.45440034752198E-10 |
| Normal-vs-Grade 3 |
1.66215999999331E-05 |
| Normal-vs-Grade 4 |
1.680260E-02 |
| Grade 1-vs-Grade 2 |
1.117250E-03 |
| Grade 1-vs-Grade 3 |
1.101100E-03 |
| Grade 1-vs-Grade 4 |
4.12010000000462E-05 |
| Grade 2-vs-Grade 3 |
5.275800E-02 |
| Grade 2-vs-Grade 4 |
3.553600E-02 |
| Grade 3-vs-Grade 4 |
4.426400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.01427763357742E-12 |
| Normal-vs-ccB subtype |
7.995100E-04 |
| ccA subtype-vs-ccB subtype |
8.41570000000846E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.74660000298965E-08 |
| Normal-vs-N1 |
8.002000E-02 |
| N0-vs-N1 |
9.736600E-01 |
|
|
